Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA User Fees: Lay-Off Notices Planned For Early September If Congress Doesn’t Pass Bill
Jul 28 2022
•
By
Derrick Gingery
Stakeholders are waiting for legislators to return to the negotiating table and complete the FDA user fee reauthorization bill. • Source: Shutterstock
More from User Fees
More from Pathways & Standards